<DOC>
	<DOCNO>NCT01095978</DOCNO>
	<brief_summary>To describe relief symptom , tolerability , compliance treatment KlacidÂ® sustain release ( SR ) dose 1000 mg daily patient acute tracheitis , acute tracheobronchitis , acute bronchitis , patient acute exacerbation chronic bronchitis mild community-acquired pneumonia . This postmarketing observational study non-interventional conduct prospective , single-arm , single-country , multicenter format . Klacid SR prescribe usual manner accordance term local market authorization regard dose , population , indication well local guideline .</brief_summary>
	<brief_title>Evaluation Treatment With Klacid SR Patients With Acute Tracheitis , Tracheobronchitis Bronchitis , Acute Exacerbation Chronic Bronchitis Mild Community-acquired Pneumonia Common Clinical Practice Ukraine</brief_title>
	<detailed_description>The postmarketing observational study observational nature . Its follow-up interventional left judgment physician observational period , defines survey patient . Follow-up patient enable two patient visit period . The screening/inclusion visit ( Visit 1 ) perform decision Klacid SR therapy daily dose 1000 mg make . The second visit patient occur 10 - 16 day screening/inclusion Visit ( upon physician 's decision ) . The physician change number time visit . As result , failure meet suggest date constitute breach protocol .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Tracheitis</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Men , woman 18 year 1 . Acute tracheitis . 2 . Acute tracheobronchitis . 3 . Acute bronchitis . 4 . Mild communityacquired pneumonia . 5 . Acute exacerbation chronic bronchitis . To decision initiate Klacid SR therapy dose 1000 mg make physician . Known hypersensitivity macrolide antibiotic Documented renal impairment ( creatinine clearance 30 ml/min ) Concomitant therapy follow drug : astemizole , cisapride , pimozide , terfenadine ergotamine dihydroergotamine Pregnancy Breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Klacid SR</keyword>
	<keyword>Clarithromycin</keyword>
	<keyword>Respiratory tract infection</keyword>
	<keyword>Bronchitis</keyword>
	<keyword>Pneumonia</keyword>
</DOC>